Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014:2014:952843.
doi: 10.1155/2014/952843. Epub 2014 May 4.

Prospective analysis of 18F-FDG PET/CT predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery

Artor Niccoli-Asabella  1 , Corinna Altini  1 , Raffaele De Luca  2 , Margherita Fanelli  1 , Domenico Rubini  1 , Cosimo Caliandro  2 , Severino Montemurro  2 , Giuseppe Rubini  1
Affiliations
Clinical Trial

Prospective analysis of 18F-FDG PET/CT predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery

Artor Niccoli-Asabella et al. Biomed Res Int. 2014.

Abstract

This study prospectively assessed (18)F-FDG PET/CT in predicting the response of locally advanced low rectal cancer (LRC) to neoadjuvant chemoradiation (nCRT).

Methods: 56 patients treated with chemoradiation underwent two (18)F-FDG PET/CT scans (baseline and 5-6 weeks post-nCRT). (18)F-FDG uptake (SUVmax and SUVmean) and differences between baseline (SUV1) and post-nCRT (SUV2) scans (ΔSUV and RI%) were evaluated. Results were related to the Mandard's TRG and (y)pTNM.

Results: (18)F-FDG PET/CT sensitivity, specificity, accuracy, PPV and NPV resulted in 88.6%, 66.7%, 83.92%, 90.7%, and 61.5%. SUV2 resulted in better than SUV1 to predict nCRT response by TRG, with no significant statistical difference between the SUVmax2 and SUVmean2 AUC (0.737 versus 0.736; P = 0.928). The same applies to the (y)pTNM (0.798 versus 0.782; P = 0.192). In relation to the TRG, RI values had a higher AUC than ΔSUV, with no significant difference between RImax and RImean (0.672 versus 0.695; P = 0.292). The same applied to the (y)pTNM (0.742 versus 0.741; P = 0.940). In both cases ΔSUV does not appear to be a good predictive tool. Logistic regression confirmed the better predictive role of SUVmax2 for the (y)pTNM (odds ratio = 1.58) and SUVmean2 for the TRG (odds ratio = 1.87).

Conclusions: (18)F-FDG PET/CT can evaluate response to nCRT in LRC, even if more studies are required to define the most significant parameter for predicting pathologic tumor changes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A 77-year-old male with a vegetans eccentric ulcerated lesion, 45 mm in length, localized 3 cm from the anal verge (cT3N0). Baseline 18F-FDG PET/CT MIP (a) and sagittal images (b) showed the rectal lesion, with value of 18.9 for SUVmax, 10.4 for SUVmean, and 3.0 SD (green arrows). The post-nCRT 18F-FDG PET/CT MIP (c) and sagittal images (d) did not show a pathological uptake of 18F-FDG (SUVmax = 2.5, SUVmean = 1.1, and std = 0.3). Histological specimen analysis showed (y)pT0N0 M0, TGR1, and R0 and the patient was classified as a complete responder. In this patient ΔSUVmax, ΔSUVmean, RImax, and RImean results were 16.4, 9.3, 86.77, and 89.42%, respectively.
Figure 2
Figure 2
A 76-year-old male with an eccentric lesion, 30 mm in length, localized 2 cm from the anal verge (G3, cT3N0). Baseline 18F-FDG PET/CT MIP (a) and sagittal images (b) showed the rectal lesion with a 12.9 value for SUVmax, 5.4 for SUVmean, and 1.5 SD (green arrows). The post-nCRT 18F-FDG PET/CT MIP (c) and sagittal images (d) showed, in the same site (green arrows), the persistence of 18F-FDG pathological uptake (SUVmax 11.8, SUVmean 5.4, and SD 1.5). Histological specimen analysis showed (y)pT3N0 M0, TGR4, and R0 and the patient was classified as a nonresponder. In this patient ΔSUVmax, ΔSUVmean, RImax, and RImean results were 1.10, 0, 8.5, and 0%, respectively.
Figure 3
Figure 3
ROC curves for 18F-FDG PET/CT assessment of SUVmax1, SUVmean1, SUVmax2, and SUVmean2 in predicting response to CRT based on Mandard's TRG (a) and the (y)pTNM (b) criteria.
Figure 4
Figure 4
ROC curves for 18F-FDG PET/CT assessment of ΔSUVmax, ΔSUVmean, RImax, and RImean in predicting response to CRT based on Mandard's TRG (a) and the (y)pTNM (b) criteria.
See this image and copyright information in PMC

References

    1. Grassetto G, Marzola MC, Minicozzi A, Al-Nahhas A, Rubello D. F-18 FDG PET/CT in rectal carcinoma: where are we now? Clinical Nuclear Medicine. 2011;36(10):884–888. - PubMed
    1. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Rectal Cancer, Version 2. 2010, http://www.nccn.org/ - PubMed
    1. Capirci C, Rampin L, Erba PA, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. 2007;34(10):1583–1593. - PubMed
    1. Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Annals of Surgical Oncology. 2006;13(3):397–404. - PubMed
    1. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New England Journal of Medicine. 2001;345(9):638–646. - PubMed

Publication types

Substances

LinkOut - more resources